Tata India Pharma & Healthcare Fund Regular Growth

Tata India Pharma & Healthcare Fund Regular Growth

Equity

Tata Mutual Fund

Sector - Healthcare

Get the latest NAV of Tata India Pharma & Healthcare Fund Regular Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹29.47

▲0.2%1D

NAV as on 24 Jun 2025

12.06%/per year

Since Inception

Absolute Gain%

▲▼

Tata India Pharma & Healthcare Fund Regular Growth Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (24-Jun-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
-0.13%
1.46%
0.9%
3 Months
1.18%
7.31%
1.45%
6 Months
-4.56%
3.17%
-2.74%
1 Year
12.95%
3.7%
15.79%
3 Years
24.09%
20.16%
24.19%
5 Years
21.07%
22.16%
21.23%

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
Tata India Pharma & Healthcare Fund Regular Growth
-
1,232Cr
2.12%
12.95%
24.09%
12.06%
SBI Healthcare Opportunities Fund Regular
1/8
3,689Cr
1.94%
17.46%
28.09%
15.44%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2/8
5,508Cr
1.9%
20.92%
29.17%
21.5%
DSP Healthcare Fund Regular
4/8
2,961Cr
1.94%
15.14%
25.36%
22.52%
See all

Tata India Pharma & Healthcare Fund Regular Growth Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

Tata India Pharma & Healthcare Fund Regular Growth Asset Allocation

See fund asset allocation details as on (14-Jun-25)

Fund Distribution

as on (14-Jun-25)

Equity 90.8%

Debt & Cash 9.2%

Mid cap
32.3%
Large cap
29.1%
Small cap
28.1%
Small Cap allocation has gone down from 29.1% to 28.1%
Small Cap allocation has gone down from 29.1% to 28.1%
Mid Cap allocation has gone down from 32.7% to 32.3%
Mid Cap allocation has gone down from 32.7% to 32.3%
Large Cap allocation has gone down from 30.2% to 29.1%
Large Cap allocation has gone down from 30.2% to 29.1%
Cash allocation has gone up from 6.6% to 9.2%
Cash allocation has gone up from 6.6% to 9.2%

Tata India Pharma & Healthcare Fund Regular Growth Sector Allocation

See fund sector allocation details as on (14-Jun-25)

Sector Allocation

Equity 90.8%

Debt & Cash 9.2%

Health
97.7%
Basic Materials
2.3%

Top 2 Sectors in May were Health, Basic Materials

May'25

Health

97%

Basic Materials

3%

Apr'25

Health

98%

Basic Materials

2%

Tata India Pharma & Healthcare Fund Regular Growth Holdings Details

as on (31-May-25)

Equity

Top Stocks bought last month
Apollo Hospitals Enterprise Ltd's allocation increased from 5.78% to 6.22%
Apollo Hospitals Enterprise Ltd's allocation increased from 5.78% to 6.22%
Divi's Laboratories Ltd's allocation increased from 5.23% to 5.63%
Divi's Laboratories Ltd's allocation increased from 5.23% to 5.63%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 3.95% to 4.35%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 3.95% to 4.35%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.8 % to 11.64 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.8 % to 11.64 %
Cipla Ltd's allocation decreased from 6.21 % to 5.83 %
Cipla Ltd's allocation decreased from 6.21 % to 5.83 %
Aurobindo Pharma Ltd's allocation decreased from 6.18 % to 5.73 %
Aurobindo Pharma Ltd's allocation decreased from 6.18 % to 5.73 %

Tata India Pharma & Healthcare Fund Regular Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio2.12%
Benchmark
Nifty Pharma TR INR
AUM₹1232 Cr
Inception Date28 December, 2015
Min Lumpsum/SIP₹5000/₹100
Exit Load
0.2%
Lock InNo Lock-in
TurnOver
28.44%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About Tata India Pharma & Healthcare Fund Regular Growth

Tata India Pharma & Healthcare Fund Regular Growth is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Tata India Pharma & Healthcare Fund Regular Growth has ₹1232 Cr worth of assets under management (AUM) as on May 2025 and is more than category average.
  2. The fund has an expense ratio 2.1.

Returns

Tata India Pharma & Healthcare Fund Regular Growth has given a CAGR return of 12.06% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 12.95%, 24.09% and 21.07% respectively.

Holdings

Tata India Pharma & Healthcare Fund Regular Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Apollo Hospitals Enterprise Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Divi's Laboratories Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Tata India Pharma & Healthcare Fund Regular Growth

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Tata India Pharma & Healthcare Fund Regular Growth has no lock in period.

Fund Manager

Meeta Shetty

Fund Manager of Tata India Pharma & Healthcare Fund Regular Growth, since 9 March 2021

Learn more about Tata Mutual Fund
Parameters
May'25
Apr'25
Mar'25
AUM
₹ 1.2K Cr
₹ 1.2K Cr
₹ 1.2K Cr
  • AUM of the fund stands at 1.2K Cr as of May'25
  • AUM increased by 8.9 Cr between May'25 and Apr'25

Frequently Asked Questions for Tata India Pharma & Healthcare Fund Regular Growth

How do I invest in Tata India Pharma & Healthcare Fund Regular Growth?

INDmoney makes it simple to invest in the Tata India Pharma & Healthcare Fund Regular Growth. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘Tata India Pharma & Healthcare Fund Regular Growth’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of Tata India Pharma & Healthcare Fund Regular Growth?

The NAV of the fund today is ₹29.47. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

Tata India Pharma & Healthcare Fund Regular Growth fund has generated a return of 12.95% in 1 year, 24.09% in 3 years, 21.07% in 5 years.

Who is the fund manager of Tata India Pharma & Healthcare Fund Regular Growth?

The fund managers are Meeta Shetty.

What is the exit load of the fund?

The exit load is 0.25% if redeemed in 0-30 Days. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 2.12%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹1232 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of Tata India Pharma & Healthcare Fund Regular Growth?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(11.64%), Apollo Hospitals Enterprise Ltd(6.22%), Cipla Ltd(5.83%)